Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The WOMEN Study: What is the Optimal Method for Ischemia Evaluation in WomeN?"A Multi-Center, Prospective, Randomized Study to Establish the Optimal Method for Detection of CAD Risk in Women at an Intermediate-High Pre-Test Likelihood CAD"

NCT00282711 is registered in ClinicalTrials.gov with Hartford Hospital as lead sponsor.

NCT NCT00282711
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00282711 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The WOMEN Study: What is the Optimal Method for Ischemia Evaluation in WomeN?"A Multi-Center, Prospective, Randomized Study to Establish the Optimal Method for Detection of CAD Risk in Women at an Intermediate-High Pre-Test Likelihood CAD"
Lead sponsor
Hartford Hospital
Phase
Observational
Overall status
Completed
Start date
June 30, 2004
Completion date
December 31, 2010
Enrollment
824 (actual)
Sites
43

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease, coronary arteriosclerosis, coronary artery disease, heart disease, myocardial ischemia